Drug Development in Pre-Clinical Research

Before testing a drug in people, researchers must determine whether it's the potential to cause serious harm, also called toxicity. the 2 sorts of preclinical research are: In Vitro, In Vivo. Usually, preclinical studies aren't very large. However, these studies must provide detailed information on dosing and toxicity levels. After preclinical testing, researchers review their findings and choose whether the drug should be tested in people.

 

    Related Conference of Drug Development in Pre-Clinical Research

    August 18-19, 2025

    37th International Conference and Expo on Nanosciences and Nanotechnology

    Valencia, Spain
    September 22-23, 2025

    35th World Nano Conference

    Dubai, UAE
    October 21-22, 2025

    42nd Global Summit on Nanoscience and Technology

    London, UK
    October 23-24, 2025

    40th International Conference on Advanced Nanotechnology & Nano Electronics

    Aix-en-Provence, France
    November 27-28, 2025

    33rd International Conference on Nanomedicine & Drug Delivery

    Paris, France
    December 22-23, 2025

    42nd Global Nanotechnology Congress

    Amsterdam, Netherlands
    January 26-27, 2026

    39th International Conference on Neonatology and Perinatology

    Rome, Italy
    February 09-10, 2026

    9th International Conference on Nanomedicine and Nanotechnology

    Singapore City, Singapore
    March 23-24, 2026

    29th World Nanotechnology Congress

    Paris, France
    June 04-05, 2026

    34th International Conference on Nanomedicine and Nanomaterials

    Zurich, Switzerland
    July 23-24, 2026

    39th International Conference on Nanomaterials and Nanotechnology

    London, UK

    Drug Development in Pre-Clinical Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in